Market Analysis
Most Approvals Buy Nothing: FDA Approval Trends
Approvals lead equipment procurement by 18–24 months — but only a fraction of them lead anywhere.
What the Framework Reveals
FDA approval trends 2023–2025 and their equipment demand implications
153–161
FDA approvals across 2023–2025
14–20
of those that will trigger meaningful equipment investment
18–24 mo
lag between approval and equipment procurement
FDA approval data is the most accessible leading indicator of bioprocessing equipment demand, and the most commonly misread. Of roughly 153 to 161 approvals across 2023 to 2025, only 14 to 20 will trigger meaningful equipment investment. This analysis sets out the filters that separate the two, the 18 to 24 month lag that determines when to engage, and a quarterly tracking framework.
Source: Market Report · Jan 2026 · MKA-44-MA, Executive Summary